ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

OTITIS MEDIA TREATMENTS IN CHILDREN: SYSTEMATIC REVIEW IN LITERATURE

AUTHORS:

Ibtihal Tariq Yamani*, Jumanah Ahmed Almansaf , Reyof Saeed Alharthi , Jazi Abdullah Alosaimi, Dana Manhal Alajlouni , Malek Abdulrahman Almalki, Abdulelah Abdullah Alojayan, Mohammed Baqer Al khalaf , Nassrain Khalid Alharbi , Haya Mohammed Bin Hassan

ABSTRACT:

This review is aiming to systematically summarize the literature on Otitis Media treatments in Children. The present review was conducted by searching in Medline, Embase, Web of Science, Science Direct, BMJ journal and Google Scholar for, researches, review articles and reports, published over the past years. Books published on Management of Otitis Media treatments in Children. If several studies had similar findings, we randomly selected one or two to avoid repetitive. Based on findings and results this review found All included RCTs had some methodological flaws. Three trials recruited a representative patient spectrum (Significant effect modifications were noted for otorrhoea, and for age and bilateral acute otitis media. In children younger than 2 years of age with bilateral acute otitis media, 55% of controls and 30% on antibiotics still had pain, fever, or both at 3–7 days, with a rate difference between these groups of −25% (95% CI −36% to −14%), resulting in a number-neededto-treat (NNT) of four children. We identified no significant differences for age alone. In children with otorrhoea the rate difference and NNT, respectively, were −36% (−53% to −19%) and three, whereas in children without otorrhoea the equivalent values were −14% (−23% to −5%) and eight.6 Antibiotics seem to be most beneficial in children younger than 2 years of age with bilateral acute otitis media, and in children with both acute otitis media and otorrhoea. For most other children with mild disease an observational policy seems justified. Keywords: antibiotics, otitis media, children.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.